About 236,000 results
Open links in new tab
Sage Therapeutics Announces Topline Results from the Phase 2 …
Sage Therapeutics to discontinue development of Alzheimer’s drug
Sage Therapeutics Announces Topline Results from the Phase 2 …
Sage Therapeutics Announces Discontinuation of the …
Sage Therapeutics Announces First Quarter 2024 Financial …
FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral …
Sage Therapeutics to Provide Business Updates at 42nd Annual …
Sage Therapeutics Announces U.S. Food and Drug Administration …
Sage Therapeutics Announces Continued Positive Zuranolone …
Sage Therapeutics (SAGE) Announces Topline Results from the …